NL6811887A - - Google Patents

Info

Publication number
NL6811887A
NL6811887A NL6811887A NL6811887A NL6811887A NL 6811887 A NL6811887 A NL 6811887A NL 6811887 A NL6811887 A NL 6811887A NL 6811887 A NL6811887 A NL 6811887A NL 6811887 A NL6811887 A NL 6811887A
Authority
NL
Netherlands
Application number
NL6811887A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6811887A publication Critical patent/NL6811887A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL6811887A 1967-08-21 1968-08-21 NL6811887A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38463/67A GB1168105A (en) 1967-08-21 1967-08-21 Quinoline Derivatives

Publications (1)

Publication Number Publication Date
NL6811887A true NL6811887A (xx) 1969-02-25

Family

ID=10403617

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6811887A NL6811887A (xx) 1967-08-21 1968-08-21

Country Status (4)

Country Link
DE (1) DE1795194A1 (xx)
FR (2) FR1590673A (xx)
GB (1) GB1168105A (xx)
NL (1) NL6811887A (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3231455A1 (de) * 1981-08-26 1983-03-10 L'Oreal, 75008 Paris Verfahren zur herstellung von nitroanilinen, deren verwendung und faerbemittel, die diese enthalten sowie neue nitroaniline
FR2512016A1 (fr) * 1981-08-26 1983-03-04 Oreal Procede de preparation de nitro-anilines, compositions tinctoriales pour cheveux les contenant et nitro-anilines nouvelles
US7741520B2 (en) * 2006-02-03 2010-06-22 The Ohio State University Research Foundation Sulfonanilide analogs as selective aromatase modulators (SAMs)

Also Published As

Publication number Publication date
FR1590673A (xx) 1970-04-20
GB1168105A (en) 1969-10-22
FR7975M (xx) 1970-06-01
DE1795194A1 (de) 1971-12-30

Similar Documents

Publication Publication Date Title
AT298283B (xx)
FR7975M (xx)
AU342066A (xx)
AU2277767A (xx)
AU3189468A (xx)
AU3151267A (xx)
AU2977667A (xx)
AU2528767A (xx)
AU2454867A (xx)
AU2256867A (xx)
AU2116667A (xx)
AU1273466A (xx)
BE709999A (xx)
BE692374A (xx)
BE709731A (xx)
BE709667A (xx)
BE709531A (xx)
BE709073A (xx)
BE695727A (xx)
BE693070A (xx)
BE692922A (xx)
BE692780A (xx)
BE692779A (xx)
BE692778A (xx)
BE692654A (xx)